INHIBITION OF INVIVO INSULIN-SECRETION BY PROSTAGLANDIN-E1
INHIBITION OF INVIVO INSULIN-SECRETION BY PROSTAGLANDIN-E1
复制标题
DOI:
10.1172/jci107766
复制
发表时间:
1974-01-01
影响因子:
15.9
通讯作者:
BIERMAN, EL
中科院分区:
文献类型:
--
作者:
ROBERTSON, RP;GAVARESKI, DJ;BIERMAN, EL
To determine the effect of prostaglandin E1(PGE1) infusion upon in vivo insulin secretion, serum insulin responses after an intravenous glucose pulse (2 g) were measured before and during an intravenous infusion of PGE1(10 μg/min) in 11 anesthetized dogs. Circulating insulin decreased significantly during PGE1infusion were significantly less than control responses. Three dogs received PGE1infusions into the thoracic aorta to preclude pulmonic and hepatic degradation of PGE1before its arrival at the pancreatic artery; inhibition of insulin secretion was again seen. Inhibition of insulin secretion could not be related to the degree of arterial hypotension induced by intravenous PGE1, and despite alpha adrenergic blockade with intravenous phentolamine, PGE1-induced inhibition of glucose-stimulated insulin responses persisted. Significant increments in systemically circulating PGE levels during intravenous PGE1infusions were documented by radioimmunoassay. These studies demonstrate that systemic PGE1infusion inhibits insulin secretion and that this effect could not be shown to be dependent upon alpha adrenergic activity.Images